Prelude Therapeutics Incorporated (PRLD) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$3.89
+4.86%
Mkt Cap $196.21M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | $20.50M | $5.60M | -72.68% | -$0.33 | -$0.20 | +39.39% |
| Q4 2025 Nov 12, 2025 | $20.50M | $6.50M | -68.29% | -$0.35 | -$0.26 | +25.71% |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.45 | -$0.41 | +8.89% |
| Q2 2025 May 6, 2025 | — | — | — | -$0.47 | -$0.42 | +10.64% |
| Q1 2025 Mar 10, 2025 | — | $4.00M | — | -$0.49 | -$0.38 | +22.45% |
| Q4 2024 Nov 6, 2024 | — | $3.00M | — | -$0.48 | -$0.43 | +10.42% |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.46 | -$0.46 | +0.00% |
| Q2 2024 May 7, 2024 | — | — | — | -$0.47 | -$0.42 | +10.64% |
| Q1 2024 Feb 15, 2024 | — | $3.42M | — | -$0.50 | -$0.47 | +6.00% |
| Q4 2023 Nov 1, 2023 | — | — | — | -$0.58 | -$0.45 | +22.41% |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.65 | -$0.54 | +16.92% |
| Q2 2023 May 8, 2023 | — | — | — | -$0.68 | -$0.58 | +14.71% |
| Q1 2023 Mar 15, 2023 | — | — | — | -$0.63 | -$0.60 | +4.76% |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.63 | -$0.63 | +0.00% |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.60 | -$0.58 | +3.33% |
| Q2 2022 May 10, 2022 | — | — | — | -$0.68 | -$0.63 | +7.35% |
| Q1 2022 Mar 16, 2022 | — | — | — | -$0.69 | -$0.71 | -2.90% |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.62 | -$0.66 | -6.45% |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.51 | -$0.58 | -13.73% |
| Q2 2021 May 11, 2021 | — | — | — | -$0.41 | -$0.47 | -14.63% |
| Q1 2021 Mar 16, 2021 | — | — | — | -$0.47 | -$0.45 | +4.26% |
| Q4 2020 Nov 10, 2020 | — | — | — | -$0.43 | -$5.25 | -1120.93% |
| Q3 2020 Sep 25, 2020 | — | — | — | — | -$0.29 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.30 | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$0.31 | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$0.21 | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$3.42 | — |
| Q1 2019 Mar 31, 2019 | — | — | — | — | -$3.42 | — |